NASDAQ:MTP

Midatech Pharma - MTP Stock Forecast, Price & News

$0.29

-0.06 (-17.39%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.29
▼
$0.35
50-Day Range: $0.29
▼
$0.81
52-Week Range: $0.29
▼
$5.25

Volume: 164,362 shs
Average Volume: 40,590 shs
Market Capitalization: $6.18 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

About Midatech Pharma (NASDAQ:MTP) Stock

Midatech Pharma Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Receive MTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Midatech Pharma and its competitors with MarketBeat's FREE daily newsletter.

MTP Stock News Headlines

March 19, 2023 | americanbankingnews.com

Midatech Pharma Stock Scheduled to Reverse Split on Monday, March 27th (NASDAQ:MTP)

February 9, 2023 | finance.yahoo.com

Midatech Pharma PLC Announces Private Placement Raising US $6.0 million

March 26, 2023 | Investor Place Media (Ad)

Biden To Unleash "Choke Point" Operation On America?

Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.

January 12, 2023 | finance.yahoo.com

Midatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 Study

January 3, 2023 | finance.yahoo.com

BIOAF: Merger with Midatech Pharma

December 13, 2022 | finance.yahoo.com

Midatech Pharma PLC Announces Proposed Acquisition of Bioasis Technologies Inc

December 13, 2022 | finance.yahoo.com

Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc

October 11, 2022 | seekingalpha.com

MTP Midatech Pharma plc

March 26, 2023 | Investor Place Media (Ad)

Biden To Unleash "Choke Point" Operation On America?

September 14, 2022 | marketwatch.com

Midatech Pharma Will Need Extra Financing in 1Q 2023; Mulling Options

September 14, 2022 | finance.yahoo.com

Midatech Pharma PLC Announces ADR Ratio Change

August 3, 2022 | thestreet.com

Midatech Pharma PLC News

June 21, 2022 | finance.yahoo.com

Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma

June 7, 2022 | uk.investing.com

Midatech Pharma: MTX110’s Path To Market Fast-Tracked In RGBM

June 1, 2022 | seekingalpha.com

Midatech Pharma climbs on FDA’s Fast Track Designation for brain tumor candidate

June 1, 2022 | finance.yahoo.com

Midatech's investigational glioblastoma treatment gets Fast Track status

April 14, 2022 | seekingalpha.com

Midatech Pharma receives noncompliance notice from Nasdaq

March 8, 2022 | finance.yahoo.com

Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser

December 13, 2021 | finance.yahoo.com

Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective

November 27, 2021 | nasdaq.com

Midatech Pharma Plc - ADR Shares Approach 52-Week Low - Market Mover

September 17, 2021 | benzinga.com

Midatech Pharma Reported H1 Revenue +157% to 430K STG; H1 Operating Loss -3.15M vs -17.42M YoY

August 20, 2021 | nasdaq.com

Midatech Pharma PLC American Depositary Shs (MTP)

June 29, 2021 | benzinga.com

Midatech Pharma Secures £10M In Equity To Fund Product Development

June 17, 2021 | baystreet.ca

Midtech Booms on Discovery

June 17, 2021 | markets.businessinsider.com

Stock Alert: Midatech Pharma Jumps 40%

June 17, 2021 | msn.com

Midatech Pharma Soars on 'Breakthrough' Drug Delivery Technology

June 9, 2021 | finance.yahoo.com

Midatech Pharma PLC Announces Investor Webinar Scheduled for 17 June 2021

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Midatech Pharma and its competitors with MarketBeat's FREE daily newsletter.

MTP Company Calendar

Today: 3/26/2023
Next Earnings (Estimated): 4/25/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:MTP
CUSIP: N/A
CIK: 1643918
Web: www.midatechpharma.com
Phone: 441235888300
Fax: N/A
Employees: 18
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $800,000.00
Price / Sales: 7.72
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $5.67 per share
Price / Book: 0.05

Miscellaneous

Outstanding Shares: 21,670,000
Free Float: 21,595,000
Market Cap: $6.18 million
Optionable: Not Optionable
Beta: 2.29

Key Executives

Stephen Anthony Stamp
Chief Executive Officer, CFO, Secretary & Director

Dmitry Zamoryakhin
Chief Scientific Officer

Dan Palmer
Vice President-Technology

Steve Ellul
Vice President-Business Development

Fiona Sharp
Group Financial Controller

Key Competitors

View All Competitors

Institutional Ownership

Armistice Capital LLC
Bought 386,828 shares on 2/15/2023
Ownership: 1.785%

View All Institutional Transactions

MTP Stock - Frequently Asked Questions

How have MTP shares performed in 2023?: Midatech Pharma's stock was trading at $0.9850 on January 1st, 2023. Since then, MTP shares have decreased by 71.1% and is now trading at $0.2851.
View the best growth stocks for 2023 here.
When is Midatech Pharma's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023.
View our MTP earnings forecast.
When did Midatech Pharma's stock split?: Midatech Pharma's stock reverse split before market open on Monday, March 27th 2023. The 1-4 reverse split was announced on Monday, March 27th 2023. The number of shares owned by shareholders will be adjusted after the market closes on Monday, March 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.
What other stocks do shareholders of Midatech Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma investors own include CRISPR Therapeutics (CRSP), Corbus Pharmaceuticals (CRBP), Pfizer (PFE), Vaxart (VXRT), Nabriva Therapeutics (NBRV), Novavax (NVAX), Plug Power (PLUG), SCYNEXIS (SCYX), Sangamo Therapeutics (SGMO) and Sorrento Therapeutics (SRNE).

What is Midatech Pharma's stock symbol?: Midatech Pharma trades on the NASDAQ under the ticker symbol "MTP."
Who are Midatech Pharma's major shareholders?: Midatech Pharma's stock is owned by many different institutional and retail investors. Top institutional investors include Armistice Capital LLC (1.79%).
How do I buy shares of Midatech Pharma?: Shares of MTP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Midatech Pharma's stock price today?: One share of MTP stock can currently be purchased for approximately $0.29.
How much money does Midatech Pharma make?: Midatech Pharma (NASDAQ:MTP) has a market capitalization of $6.18 million and generates $800,000.00 in revenue each year.
How can I contact Midatech Pharma?: Midatech Pharma's mailing address is ODDFELLOWS HOUSE 19 NEWPORT ROAD, CARDIFF X0, CF24 0AA. The official website for the company is www.midatechpharma.com. The company can be reached via phone at 441235888300 or via email at ir@midatechpharma.com.

This page (NASDAQ:MTP) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Midatech Pharma - MTP Stock Forecast, Price & News

About Midatech Pharma (NASDAQ:MTP) Stock

MTP Stock News Headlines

MTP Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

MTP Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info